Robert W. Baird Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective boosted by investment analysts at Robert W. Baird from $20.00 to $21.00 in a report issued on Monday,Benzinga reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. Robert W. Baird’s target price indicates a potential upside of 1.89% from the company’s previous close.

Several other equities research analysts also recently issued reports on the stock. Truist Financial boosted their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Cantor Fitzgerald lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, UBS Group set a $25.00 price target on Sabra Healthcare REIT in a report on Wednesday, July 22nd. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.27.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $20.61 on Monday. The firm has a market capitalization of $5.27 billion, a P/E ratio of 79.27, a P/E/G ratio of 1.57 and a beta of 0.64. Sabra Healthcare REIT has a 1-year low of $17.17 and a 1-year high of $22.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The business’s 50-day simple moving average is $20.43 and its 200-day simple moving average is $20.16.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The firm had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The firm’s revenue for the quarter was up 24.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.38 EPS. Equities analysts predict that Sabra Healthcare REIT will post 1.52 EPS for the current year.

Institutional Trading of Sabra Healthcare REIT

A number of hedge funds have recently made changes to their positions in SBRA. PNC Financial Services Group Inc. raised its stake in Sabra Healthcare REIT by 2.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after buying an additional 528 shares in the last quarter. Larson Financial Group LLC grew its position in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 553 shares in the last quarter. Inspire Investing LLC grew its position in shares of Sabra Healthcare REIT by 2.3% in the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after acquiring an additional 565 shares in the last quarter. Nissay Asset Management Corp Japan increased its holdings in shares of Sabra Healthcare REIT by 1.5% in the 2nd quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock valued at $760,000 after acquiring an additional 585 shares during the last quarter. Finally, Natixis Advisors LLC increased its holdings in shares of Sabra Healthcare REIT by 2.2% in the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock valued at $516,000 after acquiring an additional 598 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.